Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,645.00
-35.00 (-2.08%)
At close: Mar 19, 2026
Genmab Revenue
Revenue (ttm)
$23.66B
Revenue Growth
+19.19%
P/S Ratio
4.36
Revenue / Employee
$7.96M
Employees
2,973
Market Cap
103.14B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2010 | 104.39M | -8.77M | -7.75% |
| Dec 31, 2009 | 113.16M | -16.25M | -12.56% |
| Dec 31, 2008 | 129.42M | 25.30M | 24.29% |
| Dec 31, 2007 | 104.12M | 80.20M | 335.29% |
| Dec 31, 2006 | 23.92M | 8.33M | 53.41% |
| Dec 31, 2005 | 15.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| H. Lundbeck | 24.63B |
| Demant | 22.97B |
| GN Store Nord | 16.78B |
| Zealand Pharma | 9.21B |
| ALK-Abelló | 6.31B |
| Bavarian Nordic | 6.24B |
Genmab News
- 2 hours ago - Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire
- 6 hours ago - Passing of Genmab A/S' Annual General Meeting - GlobeNewsWire
- 3 days ago - Completion of Share Buy-back Program - GlobeNewsWire
- 7 days ago - Genmab A/S at Barclays Global Healthcare Conference Transcript - GuruFocus
- 8 days ago - Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Harbor Health Care ETF Q4 2025 Portfolio Review - Seeking Alpha
- 10 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 16 days ago - Genmab A/S at TD Cowen Healthcare Conference Transcript - GuruFocus